single-cell analysis market | MarketsandMarkets Blog

search report forsingle cell analysis market By cell type (human, animal, microbial), product (consumable, instrument), technology (flow cytometry, NGS, PCR, microscopy, MS), application (research, medical), end user (pharmaceutical, biotechnology, Hospitals) – Global The forecast for 2026 published by MarketsandMarkets™ is expected to reach $6.3 billion by 2026 from $3.1 billion in 2021, at a compound annual growth rate of 15.1% over the forecast period.

Growth driver: increased spread of cancer;

Cancer genomics is one of the most important areas of application of single-cell analysis. According to GLOBOCAN, the number of cancer cases will increase to nearly 30 million by 2040 from 19.3 million cases and 10 million cancer deaths in 2020. The growth in the prevalence of this disease has led to the need for extensive research for diagnosis and treatment; Single-cell analysis forms an important part of this research. Analysis of individual cells makes it possible to correctly diagnose diseases and monitor the effectiveness of treatment. Single-cell analysis assists in T-helper cell counts, DNA content determination, and monitoring of cancer cell proliferation in breast cancer and other malignancies.

Download brochure PDF:

single cell analysis market

single cell analysis market

Industry segmentation in detail:

Consumables segment dominated the single cell analysis market in 2022

On the basis of products, divided into consumables and tools. Consumables captured the largest share with 67.4% of the single-cell analysis market in 2020. The large share of this segment can be mainly attributed to the frequent purchase of these products compared to instruments, which are a one-time investment. Extensive applications of consumables in research, genetic exploration, exogenous analysis, and RNA and DNA isolation are also expected to drive market growth.

The academic and research laboratories sector captured the largest share in 2020

Based on the end users, the Single Cell Analysis market is segmented into academic and research laboratories, biotechnology, pharmaceutical companies, hospitals, diagnostic laboratories, cell banks, and IVF centers. In 2020, the academic and research laboratories segment captured the largest share of the single-cell analysis market. Factors such as the growth in funding for life sciences research and the increasing number of medical colleges and universities lead to the growth of this end user segment.

Request page templates:

Leading Key Players and Analysis:

The prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGAA (Germany), QIAGEN NV (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), and Illumina, Inc. (US), Fluidigm Corporation (US), 10X Genomics (US), and Corning Incorporated (US).

Becton, Dickinson & Company (BD) is a global medical technology company that develops, manufactures and sells a wide range of medical devices and supplies, diagnostic products and laboratory equipment. The company’s products are used by healthcare organizations, life sciences companies, clinical laboratories, and the pharmaceutical industry. BD has three main business segments, BD Medical, BD Life Sciences and BD Interventional. The BD Life Sciences division is also categorized as Pre-Analytic, Diagnostic Systems, and Biosciences. The company supplies single-cell analysis products through the biological sciences segment.

Geographical analysis in detail:

North America captured the largest share of 44.9% of the global single-cell analysis market in 2020. This market is expected to reach $2,520.2 million by 2026 from an estimated $1,282.2 million in 2021, at an average Compound annual growth of 14.5%. North America’s popularity in this market is primarily due to the presence of major players in the market, along with increased research and development expenditures and federal funding.

Talk to the analyst:


Leave a Comment